Discontinued — last reported Q3 '25

Current Liabilities

Accrued Litigation

Natera, Inc. Accrued Litigation increased by 1.2% to $33.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2014
Last reportedQ3 2025

How to read this metric

An increase indicates higher legal risk or the recognition of new settlement obligations, which can negatively impact earnings.

Detailed definition

Accrued litigation represents the estimated liability for legal claims and settlements that are probable and estimable....

Peer comparison

Highly specific to the company's legal environment; peers in the pharmaceutical industry often carry similar provisions.

Metric ID: accrued_litigation

Historical Data

2 periods
 Q4 '25Q1 '26
Value$32.60M$33.00M
QoQ Change+1.2%
Range$32.60M$33.00M

Frequently Asked Questions

What is Natera, Inc.'s accrued litigation?
Natera, Inc. (NTRA) reported accrued litigation of $33.00M in Q1 2026.
What does accrued litigation mean?
Money set aside to cover potential costs from legal disputes.